Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies
- PMID: 21798324
- DOI: 10.1016/j.ijpharm.2011.07.013
Design of multifunctional non-viral gene vectors to overcome physiological barriers: dilemmas and strategies
Abstract
Gene-based therapeutics hold great promise for medical advancement and have been used to treat various human diseases with mixed success. However, their therapeutic application in vivo is limited due largely to several physiological barriers. The design of non-viral gene vectors with the ability to overcome delivery obstacles is currently under extensive investigation. These efforts have placed an emphasis on the development of multifunctional vectors able to execute multiple tasks to simultaneously overcome both extracellular and intracellular obstacles. However, the assembly of these different functionalities into a single system to create multifunctional gene vectors faces many conflicts that largely limit the safe and efficient application of lipoplexes and polyplexes in a systemic delivery. In the review, we have described the dilemmas inherent in the design of a viable, non-viral gene vector equipped with multiple functionalities. The strategies directed towards individual delivery barriers are first summarized, followed by a focus on the design of so-called smart multifunctional vectors with the capability to overcome the delivery difficulties of gene medicines, including the so-called the "polycation dilemma", the "PEG dilemma" and the "package and release dilemma".
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
Barriers to gene delivery using synthetic vectors.Adv Genet. 2005;53:19-46. Adv Genet. 2005. PMID: 16240989 Review.
-
Intestinal delivery of non-viral gene therapeutics: physiological barriers and preclinical models.Drug Discov Today. 2011 Mar;16(5-6):203-18. doi: 10.1016/j.drudis.2011.01.003. Epub 2011 Jan 22. Drug Discov Today. 2011. PMID: 21262379 Review.
-
Polyethylenimine-based non-viral gene delivery systems.Eur J Pharm Biopharm. 2005 Jul;60(2):247-66. doi: 10.1016/j.ejpb.2004.11.011. Eur J Pharm Biopharm. 2005. PMID: 15939236 Review.
-
Non-viral gene therapy: polycation-mediated DNA delivery.Appl Microbiol Biotechnol. 2003 Jul;62(1):27-34. doi: 10.1007/s00253-003-1321-8. Epub 2003 Apr 29. Appl Microbiol Biotechnol. 2003. PMID: 12719940 Review.
-
Characterization of a multifunctional PEG-based gene delivery system containing nuclear localization signals and endosomal escape peptides.Acta Biomater. 2009 Mar;5(3):854-64. doi: 10.1016/j.actbio.2008.09.009. Epub 2008 Sep 30. Acta Biomater. 2009. PMID: 18926782
Cited by
-
Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine.Int J Nanomedicine. 2015 Apr 13;10:2895-911. doi: 10.2147/IJN.S76312. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25926734 Free PMC article.
-
Dexamethasone Conjugates: Synthetic Approaches and Medical Prospects.Biomedicines. 2021 Mar 27;9(4):341. doi: 10.3390/biomedicines9040341. Biomedicines. 2021. PMID: 33801776 Free PMC article. Review.
-
Polyion complex (PIC) particles: Preparation and biomedical applications.Eur Polym J. 2016 Aug;81:198-215. doi: 10.1016/j.eurpolymj.2016.06.003. Eur Polym J. 2016. PMID: 27524831 Free PMC article.
-
Delivery of docetaxel using pH-sensitive liposomes based on D-α-tocopheryl poly(2-ethyl-2-oxazoline) succinate: Comparison with PEGylated liposomes.Asian J Pharm Sci. 2019 Jul;14(4):391-404. doi: 10.1016/j.ajps.2018.07.005. Epub 2018 Sep 18. Asian J Pharm Sci. 2019. PMID: 32104468 Free PMC article.
-
Drug delivery nanosystems targeted to hepatic ischemia and reperfusion injury.Drug Deliv Transl Res. 2021 Apr;11(2):397-410. doi: 10.1007/s13346-021-00915-8. Epub 2021 Mar 3. Drug Deliv Transl Res. 2021. PMID: 33660214 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical